Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

December 2, 2022

Rallybio, AbCellera partner to develop therapeutics for rare diseases

US-based biotechnology firm Rallybio has entered into a strategic alliance with AbCellera to discover, develop, and commercialise new antibody-based therapeutics for rare diseases.

Rallybio, AbCellera partner to develop therapeutics for rare diseases